<div id=toc></div>

# Table of Contents

- [q-bio.QM](#q-bio.QM) [Total: 1]
- [cond-mat.soft](#cond-mat.soft) [Total: 1]
- [cs.LG](#cs.LG) [Total: 3]


<div id='q-bio.QM'></div>

# q-bio.QM [[Back]](#toc)

### [1] [ORCA: A Comprehensive AI-Driven Platform for Digital Pathology Analysis and Biomarker Discovery](https://arxiv.org/abs/2509.13044)
*Noor Shaker,Mohamed AbouZleikha,Nuha Shaker*

Main category: q-bio.QM

TL;DR: ORCA是一个专为数字病理学设计的无代码AI平台，使病理学家无需编程即可训练和部署AI模型，显著提高分析速度和可重复性。


<details>
  <summary>Details</summary>
Motivation: 数字病理学中AI解决方案实施复杂，限制了其广泛应用，需要开发易于使用的平台来降低技术门槛。

Method: 开发ORCA平台，集成先进深度学习架构和临床工作流管理，提供直观界面支持组织分类、细胞分割、空间分布评分等应用。

Result: 在多癌种验证研究中显示，相比传统手动评估方法，在分析速度、可重复性和临床相关性方面有显著改进。

Conclusion: ORCA成功实现了病理学中先进AI工具的普及化，有望加速生物标志物发现和增强精准医学计划。

Abstract: Digital pathology has emerged as a transformative approach to tissue
analysis, offering unprecedented opportunities for objective, quantitative
assessment of histopathological features. However, the complexity of
implementing artificial intelligence (AI) solutions in pathology workflows has
limited widespread adoption. Here we present ORCA (Optimized Research and
Clinical Analytics), a comprehensive no-code AI platform specifically designed
for digital pathology applications. ORCA addresses critical barriers to AI
adoption by providing an intuitive interface that enables pathologists and
researchers to train, deploy, and validate custom AI models without programming
expertise. The platform integrates advanced deep learning architectures with
clinical workflow management, supporting applications from tissue
classification and cell segmentation to spatial distribution scoring and novel
biomarker discovery. We demonstrate ORCA's capabilities through validation
studies across multiple cancer types, showing significant improvements in
analytical speed, reproducibility, and clinical correlation compared to
traditional manual assessment methods. Our results indicate that ORCA
successfully democratizes access to state-of-the-art AI tools in pathology,
potentially accelerating biomarker discovery and enhancing precision medicine
initiatives.

</details>


<div id='cond-mat.soft'></div>

# cond-mat.soft [[Back]](#toc)

### [2] [An Assembly-Line Mechanism for In-Vitro Encapsulation of Fragmented Cargo in Virus-Like Particles](https://arxiv.org/abs/2509.12409)
*Ayesha Amjad,Irina Tsvetkova,Lena G. Lowry,David Gene Morgan,Roya Zandi,Paul van der Schoot,Bogdan Dragnea*

Main category: cond-mat.soft

TL;DR: 本文通过电镜结构分析研究了病毒壳粒子与配体包装的纳米粒子协合组装时多重货物包装的机理和路径，发现了不同于传统VLP组装机制的特定"组装线"路径，详细解释了纳米粒子尺寸选择性等对药物途透应用重要的观测现象。


<details>
  <summary>Details</summary>
Motivation: 病毒壳粒子能够包装广泛的功能性货物（如siRNA、酶和光妆材料），特别是多重货物的包装能力，使其成为生物技术中推进药物途透应用和开发创新材料的关键工具。但多重货物包装的机理和路径仍不明确，需要进一步研究。

Method: 采用电子显微镜结构分析方法，利用金属纳米粒子作为货物提供的对比度，识别不同组装中间体的结构。研究病毒壳蛋白与配体包装的纳米粒子协同组装过程。

Result: 发现多重货物包装通过一种特定的"组装线"路径进行自组装，这种路径不同于之前描述的病毒类粒子（VLP）离体组装机制。详细解释了纳米粒子尺寸选择性等对药物途透应用重要的观测现象。

Conclusion: 该研究揭示了病毒壳多重货物包装的新骨架机制，为理解和优化病毒基药物途透系统提供了重要机制见解，对于推进生物医药应用和新材料开发具有重要意义。

Abstract: The ability of virus shells to encapsulate a wide range of functional
cargoes, especially multiple cargoes - siRNAs, enzymes, and chromophores - has
made them an essential tool in biotechnology for advancing drug delivery
applications and developing innovative new materials. Here we present a
mechanistic study of the processes and pathways that lead to multiple cargo
encapsulation in the co-assembly of virus shell proteins with ligand-coated
nanoparticles. Based on the structural identification of different
intermediates, enabled by the contrast in electron microscopy provided by the
metal nanoparticles that play the cargo role, we find that multiple cargo
encapsulation occurs by self-assembly via a specific ``assembly line'' pathway
that is different from previously described \emph{in vitro} assembly mechanisms
of virus-like particles (VLP). The emerging model explains observations that
are potentially important for delivery applications, for instance, the
pronounced nanoparticle size selectivity.

</details>


<div id='cs.LG'></div>

# cs.LG [[Back]](#toc)

### [3] [A Multimodal Foundation Model to Enhance Generalizability and Data Efficiency for Pan-cancer Prognosis Prediction](https://arxiv.org/abs/2509.12600)
*Huajun Zhou,Fengtao Zhou,Jiabo Ma,Yingxue Xu,Xi Wang,Xiuming Zhang,Li Liang,Zhenhui Li,Hao Chen*

Main category: cs.LG

TL;DR: MICE是一个多模态基础模型，通过协作专家机制整合病理图像、临床报告和基因组数据，在泛癌预后预测中表现出卓越的泛化能力和数据效率。


<details>
  <summary>Details</summary>
Motivation: 现有AI模型难以充分利用多模态数据的丰富信息，提取的表示泛化性差，需要开发能够有效整合多源异构数据的模型来提升肿瘤微环境理解。

Method: 采用功能多样化的专家模块替代传统多专家模块，结合对比学习和监督学习，从11,799名患者的30种癌症类型数据中学习跨癌症和癌症特异性特征。

Result: 在内部队列上C-index提升3.8%-11.2%，在独立队列上提升5.8%-8.8%，显著优于单模态和最先进的多专家多模态模型，并展现出优异的数据效率。

Conclusion: MICE为泛癌预后预测建立了有效且可扩展的基础框架，具有个性化定制治疗和改善治疗结果的强大潜力。

Abstract: Multimodal data provides heterogeneous information for a holistic
understanding of the tumor microenvironment. However, existing AI models often
struggle to harness the rich information within multimodal data and extract
poorly generalizable representations. Here we present MICE (Multimodal data
Integration via Collaborative Experts), a multimodal foundation model that
effectively integrates pathology images, clinical reports, and genomics data
for precise pan-cancer prognosis prediction. Instead of conventional
multi-expert modules, MICE employs multiple functionally diverse experts to
comprehensively capture both cross-cancer and cancer-specific insights.
Leveraging data from 11,799 patients across 30 cancer types, we enhanced MICE's
generalizability by coupling contrastive and supervised learning. MICE
outperformed both unimodal and state-of-the-art multi-expert-based multimodal
models, demonstrating substantial improvements in C-index ranging from 3.8% to
11.2% on internal cohorts and 5.8% to 8.8% on independent cohorts,
respectively. Moreover, it exhibited remarkable data efficiency across diverse
clinical scenarios. With its enhanced generalizability and data efficiency,
MICE establishes an effective and scalable foundation for pan-cancer prognosis
prediction, holding strong potential to personalize tailored therapies and
improve treatment outcomes.

</details>


### [4] [A Novel Recurrent Neural Network Framework for Prediction and Treatment of Oncogenic Mutation Progression](https://arxiv.org/abs/2509.12732)
*Rishab Parthasarathy,Achintya Bhowmik*

Main category: cs.LG

TL;DR: 这篇论文提出了一种基于人工智能的端到端桌面分析框架，通过时间序列机器学习模型预测癌症严重程度和突变进展，并推荐治疗方案，避免依赖传统的耐耗时的实验室数据。


<details>
  <summary>Details</summary>
Motivation: 癌症仍是美国第二大死因，年死亡人数超过60万。当前的桌面分析领域依靠于手工获取的实验室数据，过程耐耗时。需要一种更高效、成本效益更好的方法来预测癌症进展和推荐治疗。

Method: 使用程序性机器学习模型与桌面分析相结合的方法：1）从TCGA数据库中提取突变序列；2）使用新的预处理算法按突变频率筛选关键突变；3）通过递归神经网络预测癌症严重程度；4）结合预测结果、预处理信息和药物目标数据库预测未来突变和推荐治疗方案。

Result: 框架获得了稳健的结果，ROC曲线准确率超过60%，与现有癌症诊断方法相似。预处理算法成功识别了各癌症阶段的几百个关键驱动突变，与当前研究一致。生成了基于预测基因频率的热力图，突出显示了各癌症的关键突变。

Conclusion: 这是首个高效、成本效益好的端到端框架，能够在不依赖费时费力的实验室工作的情况下预测癌症进展并提供治疗建议，为癌症诊断和治疗提供了新的解决方案。

Abstract: Despite significant medical advancements, cancer remains the second leading
cause of death, with over 600,000 deaths per year in the US. One emerging
field, pathway analysis, is promising but still relies on manually derived wet
lab data, which is time-consuming to acquire. This work proposes an efficient,
effective end-to-end framework for Artificial Intelligence (AI) based pathway
analysis that predicts both cancer severity and mutation progression, thus
recommending possible treatments. The proposed technique involves a novel
combination of time-series machine learning models and pathway analysis. First,
mutation sequences were isolated from The Cancer Genome Atlas (TCGA) Database.
Then, a novel preprocessing algorithm was used to filter key mutations by
mutation frequency. This data was fed into a Recurrent Neural Network (RNN)
that predicted cancer severity. Then, the model probabilistically used the RNN
predictions, information from the preprocessing algorithm, and multiple
drug-target databases to predict future mutations and recommend possible
treatments. This framework achieved robust results and Receiver Operating
Characteristic (ROC) curves (a key statistical metric) with accuracies greater
than 60%, similar to existing cancer diagnostics. In addition, preprocessing
played an instrumental role in isolating important mutations, demonstrating
that each cancer stage studied may contain on the order of a few-hundred key
driver mutations, consistent with current research. Heatmaps based on predicted
gene frequency were also generated, highlighting key mutations in each cancer.
Overall, this work is the first to propose an efficient, cost-effective
end-to-end framework for projecting cancer progression and providing possible
treatments without relying on expensive, time-consuming wet lab work.

</details>


### [5] [Spatiotemporal graph neural process for reconstruction, extrapolation, and classification of cardiac trajectories](https://arxiv.org/abs/2509.12953)
*Jaume Banus,Augustin C. Ogier,Roger Hullin,Philippe Meyer,Ruud B. van Heeswijk,Jonas Richiardi*

Main category: cs.LG

TL;DR: 提出了一种基于概率框架的结构化时空动力学建模方法，整合神经ODE、图神经网络和神经过程，用于从稀疏观测中重建和预测心脏运动轨迹。


<details>
  <summary>Details</summary>
Motivation: 心脏运动具有结构化时空特性，传统方法难以从稀疏观测中准确建模其动态变化和不确定性，需要一种能够同时处理时空连续性、解剖结构和不确定性的统一框架。

Method: 使用时空多重图表示动态系统，通过GNN参数化的向量场建模潜在轨迹。基于节点和边级别的稀疏上下文观测，推断潜在初始状态和控制变量的分布，实现轨迹插值和外推。

Result: 在三个合成动力学系统和两个真实心脏影像数据集上验证，能够准确重建轨迹并从单周期观测外推未来心脏周期。在ACDC分类任务达到99%准确率，在UK Biobank房颤检测达到67%准确率。

Conclusion: 该方法为心脏运动分析提供了灵活框架，为基于图学习的结构化生物医学时空时间序列数据分析奠定了基础。

Abstract: We present a probabilistic framework for modeling structured spatiotemporal
dynamics from sparse observations, focusing on cardiac motion. Our approach
integrates neural ordinary differential equations (NODEs), graph neural
networks (GNNs), and neural processes into a unified model that captures
uncertainty, temporal continuity, and anatomical structure. We represent
dynamic systems as spatiotemporal multiplex graphs and model their latent
trajectories using a GNN-parameterized vector field. Given the sparse context
observations at node and edge levels, the model infers a distribution over
latent initial states and control variables, enabling both interpolation and
extrapolation of trajectories. We validate the method on three synthetic
dynamical systems (coupled pendulum, Lorenz attractor, and Kuramoto
oscillators) and two real-world cardiac imaging datasets - ACDC (N=150) and UK
Biobank (N=526) - demonstrating accurate reconstruction, extrapolation, and
disease classification capabilities. The model accurately reconstructs
trajectories and extrapolates future cardiac cycles from a single observed
cycle. It achieves state-of-the-art results on the ACDC classification task (up
to 99% accuracy), and detects atrial fibrillation in UK Biobank subjects with
competitive performance (up to 67% accuracy). This work introduces a flexible
approach for analyzing cardiac motion and offers a foundation for graph-based
learning in structured biomedical spatiotemporal time-series data.

</details>
